Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (5,069,818) $ (3,803,499)
Adjustments to reconcile net loss to net cash used in operating activities:    
Acquired in-process research and development 1,305,000 0
Amortization of right of use asset 27,043 26,199
Share-based expense 392,829 297,337
Changes in operating assets and liabilities:    
Prepaid expenses and other 133,253 (62,484)
Other long-term assets (313,920) 105,555
Accounts payable, accrued expenses and other liabilities (370,245) 157,524
Net cash used in operating activities (3,895,858) (3,279,368)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Net cash paid to acquire in-process research and development (500,000) 0
Net cash used in investing activities (500,000) 0
CASH FLOWS FROM FINANCING ACTIVITIES:    
Net proceeds from issuance of common stock and warrants 0 11,450,866
Proceeds from exercise of warrants 0 3,679
Net cash provided by financing activities 0 11,454,545
Net change in cash (4,395,858) 8,175,177
Cash at beginning of period 18,244,030 11,527,552
Cash at end of period 13,848,172 19,702,729
SUPPLEMENTAL CASH FLOW INFORMATION:    
Cash paid for interest 0 0
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Issuance of common stock to acquire in-process research and development 805,000 0
Issuance of common stock to vendor 0 7
Issuance of common stock from cashless exercise of purchase warrants $ 2 $ 4